Observational studyBMC cancer2026

Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx).

Hanna Lagenfelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.